Evidence map›Paper›PMID 30947564›Full record

ArticleIntegrative cancer therapies

Human Biofield Therapy and the Growth of Mouse Lung Carcinoma.

Peiying Yang, Yan Jiang, Patrea R Rhea, Tara Coway, Dongmei Chen, Mihai Gagea, Sean L Harribance, Lorenzo Cohen

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Cancer as an evolutionary reversal-time for a paradigm shift.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Peiying Yang1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yan Jiang1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Patrea R Rhea1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tara Coway1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dongmei Chen1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mihai Gagea1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sean L Harribance2 Sean Harribance Institute for Parapsychology, Inc., Sugarland, TX, USA.
Lorenzo Cohen1 The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
NCI NIH HHS P30 CA016672NCI NIH HHS R50 CA221675
6 · The paper itself

Abstract

Biofield therapies have gained popularity and are being explored as possible treatments for cancer. In some cases, devices have been developed that mimic the electromagnetic fields that are emitted from people delivering biofield therapies. However, there is limited research examining if humans could potentially inhibit the proliferation of cancer cells and suppress tumor growth through modification of inflammation and the immune system. We found that human NSCLC A549 lung cancer cells exposed to Sean L. Harribance, a purported healer, showed reduced viability and downregulation of pAkt. We further observed that the experimental exposure slowed growth of mouse Lewis lung carcinoma evidenced by significantly smaller tumor volume in the experimental mice (274.3 ± 188.9 mm

Indexed as

A549 CellsAnimalsBiomarkers, TumorCarcinomaCarcinoma, Non-Small-Cell LungCell ProliferationCytokinesHumansLungLung NeoplasmsMacrophagesMaleMiceMice, Inbred C57BLT-Lymphocytes, RegulatoryTumor MicroenvironmentBiomarkers, TumorCytokinesbiofieldimmune modulationLewis lung carcinomaPD-L1

Identifiers

PMID30947564
PMCPMC6475842
OpenAlexW2926606075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.